TMO
Thermo Fisher Scientific Inc.
C+
60.0 / 100 composite
AlphaQuality composite grade, weighted for stable earnings power businesses.
-
5yr Avg ROIC
8.5%
-
Operating Margin Trend
-1.73 pp/yr
-
5yr Avg ROE
12.6%
-
5yr Share-Count CAGR
-1.3%
-
5yr Revenue CAGR
3.2%
-
5yr EPS CAGR
-2.3%
-
Revenue-Growth Years (5)
4/5
-
5yr FCF Margin
16.1%
-
5yr FCF/NI Conversion
1.03x
-
Net Debt / EBITDA
2.68x
-
Interest Coverage (EBIT/Int)
6.12x
-
Altman Z-Score
3.11
Stability
Weight: 15%
C
52
-
EPS Volatility (σ/μ)
0.47
-
Piotroski F-Score
5
-
Negative-Revenue Years (5)
1/5
6 of 6 gurus held; 1 new buy; 3 added; 2 trimmed; 1 full exit.
- Holders
- 6
- Avg Δ position
-
+159.2%
- New buys
- 1
- Full exits
- 1